Pierrakos et al. reviewed the literature on biomarkers in sepsis in 2010 and in 2020 and found that there are over 100 different biomarkers studied, of which none have made it to clinical practice except C-reactive protein (CRP) and procalcitonin (PCT) [14, 15]. The gene discussed is CRP; the disease is Sepsis.